A5032352031- Medication Adherence and Compliance
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
- Lipoproteins and Cardiovascular Health
- Pharmaceutical Economics and Policy
- Pharmacological Effects of Natural Compounds
- Heart rate and cardiovascular health
- Health Systems, Economic Evaluations, Quality of Life
- Retinoids in leukemia and cellular processes
- Adipokines, Inflammation, and Metabolic Diseases
Washington State University Spokane
2024
Progenra (United States)
2022
BACKGROUND: HMG-CoA reductase inhibitors (statins) are well-established as an effective pharmacotherapy for dyslipidemia, a condition thought to trigger excess amyloid beta (Aβ) aggregation. Statins may therefore also offer prophylaxis against Alzheimer's Disease and Related Dementias (ADRD). METHODS: To assess associations between statin use ADRD risk, we conducted secondary analysis of United States Medicare Current Beneficiary Survey (MCBS) data from 2019-2020. Each respondent with was...
Background: Heart failure is a chronic disease linked with significant morbidity and mortality, uncontrolled resting heart rate risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safety, patient-reported outcomes (PROs) of ivabradine in patients (HF) reduced ejection fraction (HFrEF) randomized controlled trials (RCTs) observational studies.
Objective To evaluate the cost-effectiveness of a single-pill combination (SPC) perindopril/amlodipine/indapamide versus its free equivalent (FEC) in adults with hypertension Italy.